Jeffrey Conn, founding director of Warren Center for Neuroscience Drug Discovery, named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics

Guest User

by; Vanderbilt Research news

A potential new approach for the treatment of schizophrenia

New Dystonia Drug Candidates Discovered